BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 34767927)

  • 1. Nucleoporin 93 mediates β-catenin nuclear import to promote hepatocellular carcinoma progression and metastasis.
    Lin CS; Liang Y; Su SG; Zheng YL; Yang X; Jiang N; Fu L; Zhou J; Zhang Y; Deng R; Wang CH; Lu SX; Huang YH; Liu LL; Zhang C; Yun JP
    Cancer Lett; 2022 Feb; 526():236-247. PubMed ID: 34767927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repression of WT1-Mediated LEF1 Transcription by Mangiferin Governs β-Catenin-Independent Wnt Signalling Inactivation in Hepatocellular Carcinoma.
    Tan HY; Wang N; Li S; Hong M; Guo W; Man K; Cheng CS; Chen Z; Feng Y
    Cell Physiol Biochem; 2018; 47(5):1819-1834. PubMed ID: 29953980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HEG1 indicates poor prognosis and promotes hepatocellular carcinoma invasion, metastasis, and EMT by activating Wnt/β-catenin signaling.
    Zhao YR; Wang JL; Xu C; Li YM; Sun B; Yang LY
    Clin Sci (Lond); 2019 Jul; 133(14):1645-1662. PubMed ID: 31278131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TXNDC12 promotes EMT and metastasis of hepatocellular carcinoma cells via activation of β-catenin.
    Yuan K; Xie K; Lan T; Xu L; Chen X; Li X; Liao M; Li J; Huang J; Zeng Y; Wu H
    Cell Death Differ; 2020 Apr; 27(4):1355-1368. PubMed ID: 31570854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRIM65 triggers β-catenin signaling via ubiquitylation of Axin1 to promote hepatocellular carcinoma.
    Yang YF; Zhang MF; Tian QH; Zhang CZ
    J Cell Sci; 2017 Sep; 130(18):3108-3115. PubMed ID: 28754688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined Chibby and β-Catenin Predicts Clinical Outcomes in Patients with Hepatocellular Carcinoma.
    Tsai MC; Huang CC; Wei YC; Liu TT; Lin MT; Yi LN; Lin PR; Wang CC; Chu TH; Hsiao CC; Hu TH; Tai MH
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32192213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxiredoxin 4 suppresses anoikis and augments growth and metastasis of hepatocellular carcinoma cells through the β-catenin/ID2 pathway.
    Wang W; Shen XB; Huang DB; Jia W; Liu WB; He YF
    Cell Oncol (Dordr); 2019 Dec; 42(6):769-781. PubMed ID: 31256347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DDX39 promotes hepatocellular carcinoma growth and metastasis through activating Wnt/β-catenin pathway.
    Zhang T; Ma Z; Liu L; Sun J; Tang H; Zhang B; Zou Y; Li H
    Cell Death Dis; 2018 Jun; 9(6):675. PubMed ID: 29867138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A positive feedback loop involving the LINC00346/β-catenin/MYC axis promotes hepatocellular carcinoma development.
    Zhang N; Chen X
    Cell Oncol (Dordr); 2020 Feb; 43(1):137-153. PubMed ID: 31691159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DUXAP10 inhibition attenuates the proliferation and metastasis of hepatocellular carcinoma cells by regulation of the Wnt/β-catenin and PI3K/Akt signaling pathways.
    Han K; Li C; Zhang X; Shang L
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 30996112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The β-catenin/TCF-4-LINC01278-miR-1258-Smad2/3 axis promotes hepatocellular carcinoma metastasis.
    Huang WJ; Tian XP; Bi SX; Zhang SR; He TS; Song LY; Yun JP; Zhou ZG; Yu RM; Li M
    Oncogene; 2020 Jun; 39(23):4538-4550. PubMed ID: 32372060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PDZ binding kinase, regulated by FoxM1, enhances malignant phenotype via activation of β-Catenin signaling in hepatocellular carcinoma.
    Yang YF; Pan YH; Cao Y; Fu J; Yang X; Zhang MF; Tian QH
    Oncotarget; 2017 Jul; 8(29):47195-47205. PubMed ID: 28525379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocyte enhancer factor 2C regulation of hepatocellular carcinoma via vascular endothelial growth factor and Wnt/β-catenin signaling.
    Bai XL; Zhang Q; Ye LY; Liang F; Sun X; Chen Y; Hu QD; Fu QH; Su W; Chen Z; Zhuang ZP; Liang TB
    Oncogene; 2015 Jul; 34(31):4089-97. PubMed ID: 25328135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ubiquitin-like protein FAT10 promotes the invasion and metastasis of hepatocellular carcinoma by modifying β-catenin degradation.
    Yuan R; Wang K; Hu J; Yan C; Li M; Yu X; Liu X; Lei J; Guo W; Wu L; Hong K; Shao J
    Cancer Res; 2014 Sep; 74(18):5287-300. PubMed ID: 25056121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DKK1 promotes hepatocellular carcinoma cell migration and invasion through β-catenin/MMP7 signaling pathway.
    Chen L; Li M; Li Q; Wang CJ; Xie SQ
    Mol Cancer; 2013 Dec; 12():157. PubMed ID: 24325363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spermidine/spermine N1-acetyltransferase regulates cell growth and metastasis via AKT/β-catenin signaling pathways in hepatocellular and colorectal carcinoma cells.
    Wang C; Ruan P; Zhao Y; Li X; Wang J; Wu X; Liu T; Wang S; Hou J; Li W; Li Q; Li J; Dai F; Fang D; Wang C; Xie S
    Oncotarget; 2017 Jan; 8(1):1092-1109. PubMed ID: 27901475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EYA4 inhibits hepatocellular carcinoma by repressing MYCBP by dephosphorylating β-catenin at Ser552.
    Zhu XX; Li JH; Cai JP; Hou X; Huang CS; Huang XT; Wang JQ; Li SJ; Xu QC; Yin XY
    Cancer Sci; 2019 Oct; 110(10):3110-3121. PubMed ID: 31385398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AKIP1 promotes early recurrence of hepatocellular carcinoma through activating the Wnt/β-catenin/CBP signaling pathway.
    Cui Y; Wu X; Lin C; Zhang X; Ye L; Ren L; Chen M; Yang M; Li Y; Li M; Li J; Guan J; Song L
    Oncogene; 2019 Jul; 38(27):5516-5529. PubMed ID: 30936461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-629-5p promotes growth and metastasis of hepatocellular carcinoma by activating β-catenin.
    Tao X; Yang X; Wu K; Yang L; Huang Y; Jin Q; Chen S
    Exp Cell Res; 2019 Jul; 380(2):124-130. PubMed ID: 30954576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. β-catenin plays a key role in metastasis of human hepatocellular carcinoma.
    Lai TY; Su CC; Kuo WW; Yeh YL; Kuo WH; Tsai FJ; Tsai CH; Weng YJ; Huang CY; Chen LM
    Oncol Rep; 2011 Aug; 26(2):415-22. PubMed ID: 21617877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.